NDC product
Motion Sickness Relief
NDC 83059-0007 · Shield Pharmaceuticals Corp
Key facts
| Product NDC | 83059-0007 |
|---|---|
| Proprietary name | Motion Sickness Relief |
| Nonproprietary name | Meclizine HCl |
| Substances | MECLIZINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Shield Pharmaceuticals Corp |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M002 |
| Pharmacologic classes | Antiemetic [EPC], Emesis Suppression [PE] |
| Marketing start | Dec 6, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: